Holen Sie sich die Stockscreener-App
3.30
5.71%
-0.20
Vorhandelsmarkt:
3.20
-0.10
-3.03%
Schlusskurs vom Vortag:
$3.50
Offen:
$3.41
24-Stunden-Volumen:
1.22M
Relative Volume:
1.62
Marktkapitalisierung:
$154.90M
Einnahmen:
$138.90M
Nettoeinkommen (Verlust:
$-107.15M
KGV:
-1.3079
EPS:
-2.5232
Netto-Cashflow:
$-79.85M
1W Leistung:
-2.65%
1M Leistung:
-22.90%
6M Leistung:
-44.07%
1J Leistung:
-35.92%
1-Tages-Spanne:
$3.23
$3.56
1-Wochen-Bereich:
$3.23
$3.715
52-Wochen-Spanne:
$3.23
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.30 | 164.29M | 138.90M | -107.15M | -79.85M | -2.5232 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
QTRX Maintained by Canaccord Genuity -- Price Target Lowered to $4.00 - GuruFocus
Quanterix unveils Content Innovation Engine at AACR 2026 - SelectScience
Wall Street Zen Downgrades Quanterix (NASDAQ:QTRX) to Sell - MarketBeat
Quanterix (QTRX) Launches AidaBREAST Assay for Breast Cancer Pre - GuruFocus
Quanterix (QTRX) COO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Quanterix (NASDAQ: QTRX) CFO nets shares after RSU vesting and tax withholding - Stock Titan
New breast cancer test predicts recurrence risk and radiation benefit - Stock Titan
Quanterix (QTRX) to Launch Content Innovation Engine at AACR Ann - GuruFocus
Quanterix to showcase cancer research tools at AACR meeting - Investing.com
New Quanterix platform is built to move cancer biology toward the clinic - Stock Titan
Aberdeen Group plc Trims Stock Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix (NASDAQ:QTRX) Shares Down 5.7%Here's What Happened - MarketBeat
Quanterix (QTRX) Executive Chair receives 6,178-share stock grant - Stock Titan
Quanterix (QTRX) director awarded 4,310 shares for board service - Stock Titan
Quanterix (QTRX) COO gains stock via RSU vesting with tax withholding - Stock Titan
Quanterix Corp Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
Quanterix Corp (QTRX) Stock Price Quote Today & Current Price Chart - Capital.com
Quanterix Corp (QTRX) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Portfolio Shifts: Should value investors consider Quanterix Corporation2026 Big Picture & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Quanterix moves annual meeting date, sets April 6 proposal deadline - Stock Titan
Vanguard disaggregates holdings after realignment; QTRX stake now reported by subsidiaries (QTRX) - Stock Titan
Quanterix (QTRX) CLO Daniel Char granted RSUs and stock options - Stock Titan
Quanterix (QTRX) COO gains shares from RSU vesting as stock withheld for taxes - Stock Titan
Quanterix (QTRX) COO Miller details PSUs, RSUs, options and shares in Form 3 - Stock Titan
Quanterix (QTRX) CFO nets common shares from RSU vesting and tax withholding - Stock Titan
Invenomic Capital Management LP Grows Stake in Quanterix Corporation $QTRX - MarketBeat
Portolan Capital Management LLC Buys 626,229 Shares of Quanterix Corporation $QTRX - MarketBeat
Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com
Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Releases Revenue and Margin Projections for 202 - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix (QTRX) grows Q4 revenue, deepens 2025 loss, eyes 2026 cash breakeven - Stock Titan
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):